1561 related articles for article (PubMed ID: 10447065)
1. Method of melanin bleaching in MIB1-Ki67 immunostaining of pigmented lesions: A quantitative evaluation in malignant melanomas.
Li LX; Crotty KA; Kril JJ; Palmer AA; McCarthy SW
Histochem J; 1999 Apr; 31(4):237-40. PubMed ID: 10447065
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis.
Momose M; Ota H; Hayama M
Pathol Int; 2011 Jun; 61(6):345-50. PubMed ID: 21615609
[TBL] [Abstract][Full Text] [Related]
3. Semi-automated standardisation of melanin bleaching procedures of heavily pigmented melanocytic lesions for immunohistochemical analysis on an automated platform.
Orchard GE; Gabriel J; Shams M; Fernando P; Satoc J; Nwokie T; Ismail F; d'Amico C
Br J Biomed Sci; 2019 Oct; 76(4):172-177. PubMed ID: 31144600
[No Abstract] [Full Text] [Related]
4. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.
Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ
Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439
[TBL] [Abstract][Full Text] [Related]
5. Melanin Bleaching With Warm Hydrogen Peroxide and Integrated Immunohistochemical Analysis: An Automated Platform.
Liu CH; Lin CH; Tsai MJ; Chen YH; Yang SF; Tsai KB
Int J Surg Pathol; 2018 Aug; 26(5):410-416. PubMed ID: 29466906
[TBL] [Abstract][Full Text] [Related]
6. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
Kligora CJ; Fair KP; Clem MS; Patterson JW
Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
[TBL] [Abstract][Full Text] [Related]
7. Melanin bleaching in argyrophilic staining of AgNORs in pigmented lesions: a morphometric evaluation.
Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Jun; 24(3):166-72. PubMed ID: 12102129
[TBL] [Abstract][Full Text] [Related]
8. Heavily pigmented melanocytic neoplasms: comparison of two melanin-bleaching techniques and subsequent immunohistochemical staining.
Orchard GE
Br J Biomed Sci; 1999; 56(3):188-93. PubMed ID: 10824327
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bleaching protocols utilizing hematoxylin and eosin stain and immunohistochemical proliferation marker MCM3 in pigmented melanomas.
Jordan T; Williams D; Criswell S; Wang Y
J Histotechnol; 2019 Dec; 42(4):177-182. PubMed ID: 31416403
[TBL] [Abstract][Full Text] [Related]
10. The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms.
Orchard GE; Calonje E
Am J Dermatopathol; 1998 Aug; 20(4):357-61. PubMed ID: 9700373
[TBL] [Abstract][Full Text] [Related]
11. A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues.
Ugolini F; Baroni G; Nassini R; De Logu F; Massi D
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):311-316. PubMed ID: 35384882
[TBL] [Abstract][Full Text] [Related]
12. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
Kamino H; Tam ST
J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
[TBL] [Abstract][Full Text] [Related]
13. VS38 immunostaining in melanocytic lesions.
Shanks JH; Banerjee SS
J Clin Pathol; 1996 Mar; 49(3):205-7. PubMed ID: 8675729
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
15. Pigmented lesions in unusual anatomic sites.
Piris A; Rosai J
Semin Diagn Pathol; 2003 Nov; 20(4):249-59. PubMed ID: 14694978
[TBL] [Abstract][Full Text] [Related]
16. Features of small melanocytic lesions: does small mean benign? A clinical-dermoscopic study.
de Giorgi V; Savarese I; Rossari S; Gori A; Grazzini M; Crocetti E; Sara Longo A; Oranges T; Massi D
Melanoma Res; 2012 Jun; 22(3):252-6. PubMed ID: 22430838
[TBL] [Abstract][Full Text] [Related]
17. Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions.
Tran TA; Ross JS; Carlson JA; Mihm MC
Hum Pathol; 1998 Oct; 29(10):1085-90. PubMed ID: 9781646
[TBL] [Abstract][Full Text] [Related]
18. Bleaching of melanin before image cytometry of the DNA content of pigmented skin tumors.
Talve LA; Collan YU; Alanen KA
Anal Quant Cytol Histol; 1995 Oct; 17(5):344-50. PubMed ID: 8534337
[TBL] [Abstract][Full Text] [Related]
19. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.
Soyer HP
J Cutan Pathol; 1991 Aug; 18(4):264-72. PubMed ID: 1719049
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
